Physician

George K Verghese

According to 2025 Medicare claims, George Verghese (NPI: 1629193891) practices dermatology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is VERGHESE & LING M.D.P.A. (NPI: 1790713782; TIN: 521160891) and primary practice location at 20653-3348.

Verghese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 437 traditional Medicare patients, billed 6,401 HCPCS/CPT codes, and received $896,549 in Medicare payments. The top billing code was 77290 (Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved). Part D data shows 254 prescription claims across 153 beneficiaries totaling $3,229 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 5 records totaling $181. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $388,769 to $896,549. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,283 and ending at $3,229. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	879	5,662	$388,769
2016	942	7,432	$535,126
2017	918	7,732	$483,983
2018	946	10,820	$563,231
2019	1,062	13,945	$506,728
2020	930	14,300	$547,545
2021	992	12,275	$614,956
2022	981	9,480	$542,308
2023	543	6,226	$578,886
2024	437	6,401	$896,549

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	150	$10,283
2016	101	216	$13,671
2017	87	149	$68,323
2018	133	219	$73,050
2019	170	469	$42,271
2020	178	509	$62,248
2021	158	412	$112,599
2022	116	219	$6,584
2023	128	223	$4,398
2024	153	254	$3,229

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77290	Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	129	185	$374
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	239	$106
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	256	1,841	$74
77300	Calculation of radiation therapy dose	129	186	$53
77401	Superficial and/or low voltage radiation treatment delivery	125	1,458	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mupirocin	Mupirocin	156	3,322	$1,600
Dicloxacillin Sodium	Dicloxacillin Sodium	29	406	$633

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$181	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George K. Verghese?

Tedicare shows public-source Medicare data for George K. Verghese (NPI 1629193891), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George K. Verghese have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George K. Verghese?

George K. Verghese is linked to VERGHESE & LING M.D.P.A. (billing NPI 1790713782) in the available physician profile data.

Does George K. Verghese have Open Payments data?

George K. Verghese has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.